Texas Lawsuit Seeks to Take at-Home Abortion Pills Off the Market Nationwide
Both sides of the abortion issue are waiting for a federal judge in Texas to rule on a lawsuit that could force the FDA to withdraw chemical abortion pills from the market.
This case follows the FDA’s decision to expand access to the two-part drug regimen, allowing doctors to prescribe it via telehealth appointments for women to receive the abortion-inducing pills through the mail.
The Texas lawsuit claims mifepristone, the first of the two drugs taken to induce abortion, is not as safe as advertised and should not have received FDA approval back in 2000.
These chemical procedures currently account for more than 50% of all abortions in the United States. For many years, the FDA sought to expand access to the two-part at-home pill regimen even though a number of doctors and medical organizations question its safety and its approval more than two decades ago.
“From approval and then every time the FDA has loosened its restrictions, it has gone against its own rules to do so,” Dr. Ingrid Skop from the Charlotte Lozier Institute told CBN News.
Dr. Skop says it was initially approved under a category called “subpart h” which is for drugs that treat life-threatening illnesses…
